|
|
Article: Antares Receives $1.75 Million Milestone Payment.
- Article from:
- Business Wire
- Article date:
- March 26, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
$2.6 Million in Total Slated for 2007
EWING, N.J. -- Antares Pharma, Inc. (AMEX:AIS) today announced that the Company has received a $1.75 million milestone payment of $2.6 million due in 2007 from Bradley Pharmaceuticals Inc. (NYSE:BDY). The milestone was received pursuant to a marketing agreement Bradley signed with Biosante Pharmaceuticals (a licensee of Antares) for the product Elestrin[TM], a low dose transdermal estradiol therapy delivered in our proprietary Advanced Transdermal Delivery (ATD[TM]) gel system for the treatment of hot flashes in menopausal women. Additional regulatory and sales based milestone payments could bring the total of such payments to ...